Discover a next generation breakthrough in mental health treatment with intranasal esketamine. Patients who suffer from Treatment Resistant Depression may receive Spravato™ (esketamine), which is FDA-approved, in conjunction with an antidepressant. Our clinic provides patients with a comprehensive Spravato™ program, which includes a in-depth consultation with one of our providers, who will prescribe an individualized esketamine dose and treatment schedule and determine the optimal antidepressant.

Resistant depression and resistant obsessive-compulsive disorder (OCD) are associated with considerable distress and functional impairment. We offer Transcranial Magnetic Stimulation (TMS) , which is FDA approved for both resistant depression and OCD, and recommended by the American Psychiatric Association (APA). This is a non-invasive treatment with precisely targeted magnetic pulses that stimulate and activate or deactivate key areas of the brain that are dysregulated in these conditions.